.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Colorcon
Harvard Business School
Citi
Novartis
Federal Trade Commission
Fuji
QuintilesIMS
Farmers Insurance
Julphar

Generated: January 23, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to Japan Patent: 11-261852

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Metuchen PharmsSTENDRAavanafilTABLET;ORAL202276-001Apr 27, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF ERECTILE DYSFUNCTION
Metuchen PharmsSTENDRAavanafilTABLET;ORAL202276-002Apr 27, 2012RXYesNo➤ Subscribe➤ SubscribeYYTREATMENT OF ERECTILE DYSFUNCTION
Metuchen PharmsSTENDRAavanafilTABLET;ORAL202276-003Apr 27, 2012RXYesYes➤ Subscribe➤ SubscribeYYTREATMENT OF ERECTILE DYSFUNCTION
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist